speb/financial-data huggingface dataset:
Financial ratios for FREQ.V — quarterly report dated 2025-09-30
Total revenue: 122272.66187050361
Gross profit: 65731.654676259
Operating income: -564499.2805755396
Net income: -572628.0575539569
Capital expenditures: 0
Operating cash flow: -317356.8345323741
Depreciation & amortization: 6265.467625899281
Net tangible assets: 790523.7410071943
Owner earnings: -566362.5899280576
Return on net tangible assets (%): -71.64396975686823
Buffett classification: The Gruesome
Stock price: 0.1798561151079137
Shares outstanding: 58946121
Book value: 843592.8057553957
P/B ratio: 12.567461755731312
Market cap (USD): 10601820.323741008
Debt to equity: 0.5358129071102189
Current ratio: 2.3953763812364
Quick ratio: 2.3358318331424
Interest coverage ratio: -65.95948217888366
COGS to revenue (%): 46.241740655099164
R&D to revenue (%): 0
SG&A to revenue (%): 423.6504098047176
Free cash flow (dilution-adjusted): -660489.2086330936
Buyback yield (%): 0
Retained earnings: -7698564.028776979
Inventory turnover: 1.6000651492324607
Receivables turnover: 2.5615909810245823
Capitalized R&D asset: 987.3941605839417
ROCI (R&D-adjusted, %): -63.94430998955312
Rosenberg metric: -48.802690982429496
FCF margin (%): -540.1773368871316
Revenue growth (%): -33.04011401743217
Rule of 40 score: -573.2174509045637
Financial ratios for FREQ.V — quarterly report dated 2025-12-31
Total revenue: 139310.21897810217
Gross profit: 77143.79562043794
Operating income: -420220.43795620435
Net income: -426531.38686131383
Capital expenditures: 0
Operating cash flow: -366774.4525547445
Depreciation & amortization: 6357.664233576642
Net tangible assets: 421688.3211678832
Owner earnings: -420173.7226277372
Return on net tangible assets (%): -99.64082511558507
Buffett classification: The Gruesome
Stock price: 0.20437956204379562
Shares outstanding: 58946121
Book value: 469535.76642335753
P/B ratio: 25.658071771465533
Market cap (USD): 12047382.394160584
Debt to equity: 0.7539641577952444
Current ratio: 1.7546963221802092
Quick ratio: 1.5922021995408127
Interest coverage ratio: -66.4936474936475
COGS to revenue (%): 44.62445311885987
R&D to revenue (%): 0
SG&A to revenue (%): 220.23473317439942
Free cash flow (dilution-adjusted): -415897.08029197075
Buyback yield (%): 0
Retained earnings: -8237483.211678832
Inventory turnover: 0.6864622626301706
Receivables turnover: 9.309545875810935
Capitalized R&D asset: 486.3284671532847
ROCI (R&D-adjusted, %): -89.50891530537928
FCF margin (%): -298.54025307170366
Revenue growth (%): 13.934069028155028
Rule of 40 score: -284.60618404354864
Financial ratios for FREQ.V — annual report dated 2025-12-31
Total revenue: 647056.2043795619
Gross profit: 418311.67883211677
Operating income: -1207440.8759124086
Net income: -1234161.313868613
Capital expenditures: 0
Operating cash flow: -892509.4890510949
Depreciation & amortization: 25429.197080291968
Net tangible assets: 421688.3211678832
Owner earnings: -1208732.116788321
Return on net tangible assets (%): -286.6411176483825
Buffett classification: The Gruesome
Stock price: 0.20437956204379562
Shares outstanding: 58946121
Book value: 469535.76642335753
P/B ratio: 25.658071771465533
Market cap (USD): 12047382.394160584
Debt to equity: 0.7539641577952444
Current ratio: 1.7546963221802092
Quick ratio: 1.5922021995408127
Interest coverage ratio: -40.17569339874678
COGS to revenue (%): 35.35156977078673
R&D to revenue (%): 0.22775805529139836
SG&A to revenue (%): 177.4299550913909
Free cash flow (dilution-adjusted): -1298125.5474452553
Buyback yield (%): 0
Retained earnings: -8237483.211678832
Inventory turnover: 2.525872908405068
Receivables turnover: 43.240183405687524
Capitalized R&D asset: 18634.976124240722
ROCI (R&D-adjusted, %): -250.5988714611016
Rosenberg metric: -62.75273970161316
FCF margin (%): -200.62021485289358
Revenue growth (%): -11.675980994552972
Rule of 40 score: -212.29619584744654
Financial ratios for GEVO — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.28
Shares outstanding: 243411329
Market cap (USD): 1041800488.12
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GEVO — annual report dated 2022-12-31
Total revenue: 1175000
Gross profit: -7523000
Operating income: -77438000
Net income: -98007000
Capital expenditures: 84077000
Operating cash flow: -44311000
Depreciation & amortization: 7887000
Net tangible assets: 597786000
Owner earnings: -174197000
Return on net tangible assets (%): -29.140361266406373
Buffett classification: The Gruesome
Stock price: 1.9
Shares outstanding: 243411329
Book value: 605477000
P/B ratio: 0.7638300465583333
Market cap (USD): 462481525.09999996
Debt to equity: 0.11510098649494531
Current ratio: 16.33204906431829
Quick ratio: 16.08252083660953
Interest coverage ratio: -66.35646958011996
COGS to revenue (%): 740.2553191489361
R&D to revenue (%): 1488.340425531915
SG&A to revenue (%): 3399.2340425531916
Free cash flow (dilution-adjusted): -145817000
Buyback yield (%): 0
Retained earnings: -655382000
Inventory turnover: 1.3704112178982197
Receivables turnover: 1.1868686868686869
Capitalized R&D asset: 17488000
ROCI (R&D-adjusted, %): -9.494707467282526
FCF margin (%): -12409.95744680851
Rule of 40 score: -12409.95744680851
Financial ratios for GEVO — annual report dated 2023-12-31
Total revenue: 17200000
Gross profit: 5209000
Operating income: -81835000
Net income: -66215000
Capital expenditures: 54421000
Operating cash flow: -53719000
Depreciation & amortization: 19007000
Net tangible assets: 550865000
Owner earnings: -101629000
Return on net tangible assets (%): -18.448984778484746
Buffett classification: The Gruesome
Stock price: 1.16
Shares outstanding: 243411329
Book value: 557389000
P/B ratio: 0.506571069109724
Market cap (USD): 282357141.64
Debt to equity: 0.12591027092389695
Current ratio: 4.226171986087109
Quick ratio: 4.184509876840286
Interest coverage ratio: -37.869042110134195
COGS to revenue (%): 69.71511627906976
R&D to revenue (%): 124.23837209302326
SG&A to revenue (%): 247.8372093023256
Free cash flow (dilution-adjusted): -125261000
Buyback yield (%): 0
Retained earnings: -721597000
Inventory turnover: 3.1480703596744553
Receivables turnover: 4.350025290844714
Capitalized R&D asset: 33085960
ROCI (R&D-adjusted, %): -12.402123425067433
Rosenberg metric: 0.7280420860018298
FCF margin (%): -728.2616279069767
Revenue growth (%): 1363.8297872340424
Rule of 40 score: 635.5681593270657
Financial ratios for GEVO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.63
Shares outstanding: 243411329
Market cap (USD): 396760466.27
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GEVO — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.09
Shares outstanding: 243411329
Market cap (USD): 508729677.60999995
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GEVO — annual report dated 2024-12-31
Total revenue: 16915000
Gross profit: 4913000
Operating income: -85892000
Net income: -78640000
Capital expenditures: 51085000
Operating cash flow: -57383000
Depreciation & amortization: 18298000
Net tangible assets: 477619000
Owner earnings: -111427000
Return on net tangible assets (%): -23.32968328311897
Buffett classification: The Gruesome
Stock price: 2.09
Shares outstanding: 243411329
Book value: 489488000
P/B ratio: 1.0393098045508775
Market cap (USD): 508729677.60999995
Debt to equity: 0.14426707089857158
Current ratio: 8.362177250523377
Quick ratio: 8.177373671031567
Interest coverage ratio: -22.14282031451405
COGS to revenue (%): 70.95477386934674
R&D to revenue (%): 140.3606266627254
SG&A to revenue (%): 270.7537688442211
Free cash flow (dilution-adjusted): -123201000
Buyback yield (%): 0.9258355089735415
Retained earnings: -800237000
Inventory turnover: 2.6659262549977787
Receivables turnover: 5.385227634511302
Capitalized R&D asset: 43830270
ROCI (R&D-adjusted, %): -13.757858866627068
Rosenberg metric: -0.013851841452571482
FCF margin (%): -728.353532367721
Revenue growth (%): -1.6569767441860463
Rule of 40 score: -730.010509111907
Financial ratios for GEVO — quarterly report dated 2025-03-31
Total revenue: 29109000
Gross profit: 7663000
Operating income: -15701000
Net income: -21728000
Capital expenditures: 5834000
Operating cash flow: -24048000
Depreciation & amortization: 5977000
Net tangible assets: 376119000
Owner earnings: -21585000
Return on net tangible assets (%): -5.7388751964139
Buffett classification: The Gruesome
Stock price: 1.16
Shares outstanding: 243411329
Book value: 474792000
P/B ratio: 0.5946965021314596
Market cap (USD): 282357141.64
Debt to equity: 0.36093068122462046
Current ratio: 2.0364923426868247
Quick ratio: 1.7073161166343118
Interest coverage ratio: -4.7665452337583485
COGS to revenue (%): 73.67480847847744
R&D to revenue (%): 20.797691435638463
SG&A to revenue (%): 38.07757051083857
Free cash flow (dilution-adjusted): -31780000
Buyback yield (%): 0
Retained earnings: -821965000
Inventory turnover: 1.2775361887174599
Receivables turnover: 2.436715218483174
Capitalized R&D asset: 6054000
ROCI (R&D-adjusted, %): -1.8432284070493017
FCF margin (%): -109.1758562643856
Rule of 40 score: -109.1758562643856
Financial ratios for GEVO — quarterly report dated 2025-06-30
Total revenue: 43413000
Gross profit: 26148000
Operating income: 5796000
Net income: 2729000
Capital expenditures: 5243000
Operating cash flow: -2522000
Depreciation & amortization: 7213000
Net tangible assets: 360219000
Owner earnings: 4699000
Return on net tangible assets (%): 1.3044842165460455
Capex to operating income (%): 90.45893719806763
Buffett classification: The Gruesome
Stock price: 1.32
P/E ratio: 29.4341291938439
Shares outstanding: 243411329
Book value: 479768000
P/B ratio: 0.6697048454252889
Market cap (USD): 321302954.28000003
Debt to equity: 0.35708300678661353
Current ratio: 2.327379733180397
Quick ratio: 2.096076905220324
Interest coverage ratio: 1.3339470655926353
COGS to revenue (%): 40.58692096837353
R&D to revenue (%): 4.065602469306429
SG&A to revenue (%): 24.838182111349134
Free cash flow (dilution-adjusted): -10009000
Buyback yield (%): 0
Retained earnings: -819945000
Inventory turnover: 1.0402030816459058
Receivables turnover: 2.741585096305652
Capitalized R&D asset: 5821180
ROCI (R&D-adjusted, %): 0.7806248984239684
Rosenberg metric: 3.0533531549388835
FCF margin (%): -23.055306014327506
Revenue growth (%): 49.139441409873236
Rule of 40 score: 26.08413539554573
Financial ratios for GEVO — quarterly report dated 2025-09-30
Total revenue: 42710000
Gross profit: 20425000
Operating income: -3600000
Net income: -7577000
Capital expenditures: 7830000
Operating cash flow: -6786000
Depreciation & amortization: 7404000
Net tangible assets: 345754000
Owner earnings: -8003000
Return on net tangible assets (%): -2.3146514573945636
Buffett classification: The Gruesome
Stock price: 1.96
Shares outstanding: 243411329
Book value: 474827000
P/B ratio: 1.0047579536125788
Market cap (USD): 477086204.84
Debt to equity: 0.3532949895435601
Current ratio: 1.9077309517164387
Quick ratio: 1.6019676248953392
Interest coverage ratio: -0.6913769925100826
COGS to revenue (%): 52.17747600093655
R&D to revenue (%): 10.54085694216811
SG&A to revenue (%): 27.269960196675253
Free cash flow (dilution-adjusted): -16978000
Buyback yield (%): 0
Retained earnings: -827814000
Inventory turnover: 1.0170690520743007
Receivables turnover: 5.408382930226669
Capitalized R&D asset: 7682370
ROCI (R&D-adjusted, %): -0.515912504265534
Rosenberg metric: -3.2424929178470254
FCF margin (%): -39.751814563334115
Revenue growth (%): -1.6193306152534954
Rule of 40 score: -41.37114517858761
Financial ratios for GEVO — annual report dated 2025-12-31
Total revenue: 160580000
Gross profit: 75339000
Operating income: -18865000
Net income: -32629000
Capital expenditures: 28113000
Operating cash flow: -13401000
Depreciation & amortization: 27342000
Net tangible assets: 327776000
Owner earnings: -33400000
Return on net tangible assets (%): -10.189885775651666
Buffett classification: The Gruesome
Stock price: 2
Shares outstanding: 243411329
Book value: 471169000
P/B ratio: 1.0332230218881124
Market cap (USD): 486822658
Debt to equity: 0.3555454624561463
Current ratio: 1.8248266208563975
Quick ratio: 1.5820830947381817
Interest coverage ratio: -1.0743166287015946
COGS to revenue (%): 53.08319840577905
R&D to revenue (%): 10.091543156059284
SG&A to revenue (%): 31.884418981193175
Free cash flow (dilution-adjusted): -52723000
Buyback yield (%): 0
Retained earnings: -834152000
Inventory turnover: 4.468494443279513
Receivables turnover: 17.119402985074625
Capitalized R&D asset: 39163910
ROCI (R&D-adjusted, %): -3.39932270496552
Rosenberg metric: 2.9663044393901106
FCF margin (%): -32.83285589737203
Revenue growth (%): 849.3349098433343
Rule of 40 score: 816.5020539459623
Financial ratios for GEVO — quarterly report dated 2025-12-31
Total revenue: 45348000
Gross profit: 21103000
Operating income: -5360000
Net income: -6008000
Capital expenditures: 9206000
Operating cash flow: 19955000
Depreciation & amortization: 7103000
Net tangible assets: 327776000
Owner earnings: -8111000
Return on net tangible assets (%): -2.4745557942009175
Buffett classification: The Gruesome
Stock price: 2
Shares outstanding: 243411329
Book value: 471169000
P/B ratio: 1.0332230218881124
Market cap (USD): 486822658
Debt to equity: 0.3555454624561463
Current ratio: 1.8248266208563975
Quick ratio: 1.5820830947381817
Interest coverage ratio: -1.137038608400509
COGS to revenue (%): 53.46432036694011
R&D to revenue (%): 8.564876069506925
SG&A to revenue (%): 39.00061744729646
Free cash flow (dilution-adjusted): 6044000
Buyback yield (%): 0
Retained earnings: -834152000
Inventory turnover: 1.2709687565527363
Receivables turnover: 4.83454157782516
Capitalized R&D asset: 7482790
ROCI (R&D-adjusted, %): -0.7501490740552218
Rosenberg metric: 0.1505997334517992
FCF margin (%): 13.328040927935081
Revenue growth (%): 6.176539452118942
Rule of 40 score: 19.504580380054023
Financial ratios for GPK — annual report dated 2021-12-31
Capital expenditures: 27000000
Buffett classification: The Gruesome
Stock price: 17.83
Shares outstanding: 295887387
Market cap (USD): 5275672110.209999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GPK — annual report dated 2022-12-31
Total revenue: 9440000000
Gross profit: 1830000000
Operating income: 1037000000
Net income: 522000000
Capital expenditures: 27000000
Operating cash flow: 1090000000
Depreciation & amortization: 553000000
Net tangible assets: -547000000
Owner earnings: 1048000000
Return on net tangible assets (%): -191.59049360146253
Capex to operating income (%): 2.6036644165863065
Buffett classification: The Great
Stock price: 20.66
P/E ratio: 11.710791983563219
Shares outstanding: 295887387
Book value: 2150000000
P/B ratio: 2.843271356009302
Market cap (USD): 6113033415.42
Debt to equity: 2.5595348837209304
Current ratio: 1.3998965338851526
Quick ratio: 0.5690636316606311
Effective tax rate (%): 27.09497206703911
Interest coverage ratio: 5.2639593908629445
COGS to revenue (%): 80.61440677966102
SG&A to revenue (%): 8.19915254237288
Free cash flow (dilution-adjusted): 507000000
Buyback yield (%): 0.7524905701311227
Retained earnings: 469000000
Inventory turnover: 4.738480697384807
Receivables turnover: 10.73947667804323
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.352590827873735
FCF margin (%): 5.370762711864407
Rule of 40 score: 5.370762711864407
Financial ratios for GPK — annual report dated 2023-12-31
Total revenue: 9428000000
Gross profit: 2117000000
Operating income: 1248000000
Net income: 723000000
Capital expenditures: 23000000
Operating cash flow: 1144000000
Depreciation & amortization: 619000000
Net tangible assets: -142000000
Owner earnings: 1319000000
Return on net tangible assets (%): -928.8732394366198
Capex to operating income (%): 1.842948717948718
Buffett classification: The Great
Stock price: 23.28
P/E ratio: 9.527328311701245
Shares outstanding: 295887387
Book value: 2782000000
P/B ratio: 2.4760094785621853
Market cap (USD): 6888258369.360001
Debt to equity: 1.953630481667865
Current ratio: 1.0988798764001546
Quick ratio: 0.4213982232522209
Effective tax rate (%): 22.532188841201716
Interest coverage ratio: 5.2217573221757325
COGS to revenue (%): 77.54560882477726
SG&A to revenue (%): 8.53839626644039
Free cash flow (dilution-adjusted): 296000000
Buyback yield (%): 1.103326790674103
Retained earnings: 1029000000
Inventory turnover: 4.168187001140251
Receivables turnover: 11.291017964071857
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.535290006988118
FCF margin (%): 3.1395842172252864
Revenue growth (%): -0.1271186440677966
Rule of 40 score: 3.0124655731574896
Financial ratios for GPK — quarterly report dated 2024-09-30
Capital expenditures: 8000000
Buffett classification: The Gruesome
Stock price: 28.24
Shares outstanding: 295887387
Market cap (USD): 8355859808.879999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GPK — annual report dated 2024-12-31
Total revenue: 8807000000
Gross profit: 1962000000
Operating income: 1124000000
Net income: 658000000
Capital expenditures: 34000000
Operating cash flow: 840000000
Depreciation & amortization: 557000000
Net tangible assets: 352000000
Owner earnings: 1181000000
Return on net tangible assets (%): 335.5113636363636
Capex to operating income (%): 3.0249110320284696
Buffett classification: The Great
Stock price: 26.01
P/E ratio: 11.696095647218845
Shares outstanding: 295887387
Book value: 3013000000
P/B ratio: 2.5542751197709928
Market cap (USD): 7696030935.870001
Debt to equity: 1.7414537006306008
Current ratio: 1.462953231739359
Quick ratio: 0.5412506568575933
Effective tax rate (%): 25.84650112866817
Interest coverage ratio: 4.886956521739131
COGS to revenue (%): 77.72226637901669
SG&A to revenue (%): 8.788463722039287
Free cash flow (dilution-adjusted): -425000000
Buyback yield (%): 2.9235849215640504
Retained earnings: 1410000000
Inventory turnover: 3.902508551881414
Receivables turnover: 11.603425559947299
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.163185802402337
FCF margin (%): -4.82570682411718
Revenue growth (%): -6.586762834111158
Rule of 40 score: -11.41246965822834
Financial ratios for GPK — quarterly report dated 2024-12-31
Capital expenditures: 10000000
Buffett classification: The Gruesome
Stock price: 26.01
Shares outstanding: 295887387
Market cap (USD): 7696030935.870001
Buyback yield (%): 0.32484276906267223
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GPK — quarterly report dated 2025-03-31
Total revenue: 2120000000
Gross profit: 445000000
Operating income: 233000000
Net income: 127000000
Capital expenditures: 4000000
Operating cash flow: -174000000
Depreciation & amortization: 131000000
Net tangible assets: 461000000
Owner earnings: 254000000
Return on net tangible assets (%): 55.09761388286334
Capex to operating income (%): 1.7167381974248928
Buffett classification: The Great
Stock price: 24.96
P/E ratio: 14.538088936062993
Shares outstanding: 295887387
Book value: 3158000000
P/B ratio: 2.3386159529829005
Market cap (USD): 7385349179.52
Debt to equity: 1.8084230525649145
Current ratio: 1.8815286624203822
Quick ratio: 0.7261146496815286
Effective tax rate (%): 25.294117647058822
Interest coverage ratio: 4.568627450980392
COGS to revenue (%): 79.00943396226415
SG&A to revenue (%): 9.245283018867925
Free cash flow (dilution-adjusted): -483000000
Buyback yield (%): 0
Retained earnings: 1504000000
Inventory turnover: 0.9233737596471885
Receivables turnover: 2.4565469293163384
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.347134078775058
FCF margin (%): -22.78301886792453
Rule of 40 score: -22.78301886792453
Financial ratios for GPK — quarterly report dated 2025-06-30
Total revenue: 2204000000
Gross profit: 420000000
Operating income: 206000000
Net income: 104000000
Capital expenditures: 228000000
Operating cash flow: 267000000
Depreciation & amortization: 130000000
Net tangible assets: 457000000
Owner earnings: 6000000
Return on net tangible assets (%): 1.312910284463895
Capex to operating income (%): 110.67961165048543
Buffett classification: The Gruesome
Stock price: 20.37
P/E ratio: 26.091887762727275
Shares outstanding: 295887387
Book value: 3219000000
P/B ratio: 1.8723908273345762
Market cap (USD): 6027226073.190001
Debt to equity: 1.8126747437092265
Current ratio: 1.4324324324324325
Quick ratio: 0.5612934362934363
Effective tax rate (%): 25.179856115107913
Interest coverage ratio: 3.8867924528301887
COGS to revenue (%): 80.94373865698729
SG&A to revenue (%): 9.25589836660617
Free cash flow (dilution-adjusted): 36000000
Buyback yield (%): 0
Retained earnings: 1494000000
Inventory turnover: 0.9883656509695291
Receivables turnover: 2.5450346420323324
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.118687647845315
FCF margin (%): 1.6333938294010888
Revenue growth (%): 3.9622641509433962
Rule of 40 score: 5.595657980344485
Financial ratios for GPK — quarterly report dated 2025-09-30
Total revenue: 2190000000
Gross profit: 434000000
Operating income: 256000000
Net income: 142000000
Capital expenditures: 267000000
Operating cash flow: 227000000
Depreciation & amortization: 126000000
Net tangible assets: 539000000
Owner earnings: 1000000
Return on net tangible assets (%): 0.1855287569573284
Capex to operating income (%): 104.296875
Buffett classification: The Gruesome
Stock price: 19.02
P/E ratio: 15.087876945683647
Shares outstanding: 295887387
Book value: 3286000000
P/B ratio: 1.712653104303104
Market cap (USD): 5627778100.74
Debt to equity: 1.800973828362751
Current ratio: 1.5448487954894925
Quick ratio: 0.6299333675038442
Effective tax rate (%): 22.099447513812155
Interest coverage ratio: 4.830188679245283
COGS to revenue (%): 80.18264840182648
SG&A to revenue (%): 7.442922374429224
Free cash flow (dilution-adjusted): -41000000
Buyback yield (%): 0.7107600776715126
Retained earnings: 1575000000
Inventory turnover: 0.9837535014005602
Receivables turnover: 2.4118942731277535
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.5788254256069303
FCF margin (%): -1.872146118721461
Revenue growth (%): -0.6352087114337568
Rule of 40 score: -2.5073548301552178
Financial ratios for GPK — annual report dated 2025-12-31
Total revenue: 8617000000
Gross profit: 1602000000
Operating income: 845000000
Net income: 444000000
Capital expenditures: 922000000
Operating cash flow: 841000000
Depreciation & amortization: 536000000
Net tangible assets: 601000000
Owner earnings: 58000000
Return on net tangible assets (%): 9.650582362728786
Capex to operating income (%): 109.11242603550295
Buffett classification: The Gruesome
Stock price: 14.74
P/E ratio: 9.822928117972973
Shares outstanding: 295887387
Book value: 3337000000
P/B ratio: 1.3069763513275399
Market cap (USD): 4361380084.38
Debt to equity: 1.6895415043452202
Current ratio: 1.302584670231729
Quick ratio: 0.5155971479500892
Effective tax rate (%): 23.883161512027492
Interest coverage ratio: 3.840909090909091
COGS to revenue (%): 81.40884298479749
SG&A to revenue (%): 8.16989671579436
Free cash flow (dilution-adjusted): -83000000
Buyback yield (%): 4.21884808111506
Retained earnings: 1614000000
Inventory turnover: 3.9722536806342017
Receivables turnover: 11.338157894736842
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.865806316231245
FCF margin (%): -0.9632122548450737
Revenue growth (%): -2.1573748154876804
Rule of 40 score: -3.1205870703327543
Financial ratios for GPK — quarterly report dated 2025-12-31
Total revenue: 2103000000
Gross profit: 303000000
Operating income: 150000000
Net income: 71000000
Capital expenditures: 114000000
Operating cash flow: 521000000
Depreciation & amortization: 149000000
Net tangible assets: 601000000
Owner earnings: 106000000
Return on net tangible assets (%): 17.637271214642265
Capex to operating income (%): 76
Buffett classification: The Gruesome
Stock price: 14.74
P/E ratio: 9.822928117972973
Shares outstanding: 295887387
Book value: 3337000000
P/B ratio: 1.3069763513275399
Market cap (USD): 4361380084.38
Debt to equity: 1.6895415043452202
Current ratio: 1.302584670231729
Quick ratio: 0.5155971479500892
Effective tax rate (%): 22.82608695652174
Interest coverage ratio: 2.380952380952381
COGS to revenue (%): 85.59201141226819
SG&A to revenue (%): 6.704707560627675
Free cash flow (dilution-adjusted): 405000000
Buyback yield (%): 0.779569754119087
Retained earnings: 1614000000
Inventory turnover: 1.0192525481313703
Receivables turnover: 2.767105263157895
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.5738117721120555
FCF margin (%): 19.258202567760343
Revenue growth (%): -3.9726027397260277
Rule of 40 score: 15.285599828034314
Financial ratios for HUBS — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 659.15
Shares outstanding: 51190708
Market cap (USD): 33742355178.199997
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HUBS — annual report dated 2022-12-31
Total revenue: 1730969000
Gross profit: 1422949000
Operating income: -102862000
Net income: -107347000
Capital expenditures: 37426000
Operating cash flow: 273174000
Depreciation & amortization: 58150000
Net tangible assets: 864761000
Owner earnings: -86623000
Return on net tangible assets (%): -10.016987352574873
Buffett classification: The Gruesome
Stock price: 289.13
Shares outstanding: 51190708
Book value: 992224000
P/B ratio: 14.916762146491116
Market cap (USD): 14800769404.039999
Debt to equity: 0.8126582303995872
Current ratio: 2.303672407251071
Quick ratio: 2.303672407251071
Interest coverage ratio: -27.342371079213184
COGS to revenue (%): 17.794657212231993
R&D to revenue (%): 25.53610145531203
SG&A to revenue (%): 62.61169321923155
Free cash flow (dilution-adjusted): -94446000
Buyback yield (%): 0
Retained earnings: -642381000
Receivables turnover: 7.630489885342232
Capitalized R&D asset: 442022000
ROCI (R&D-adjusted, %): 8.62067906547116
FCF margin (%): -5.4562502274737446
Rule of 40 score: -5.4562502274737446
Financial ratios for HUBS — annual report dated 2023-12-31
Total revenue: 2170230000
Gross profit: 1831868000
Operating income: -104086000
Net income: -164510000
Capital expenditures: 33718000
Operating cash flow: 350971000
Depreciation & amortization: 72673000
Net tangible assets: 1012042000
Owner earnings: -125555000
Return on net tangible assets (%): -12.406105675456157
Buffett classification: The Gruesome
Stock price: 580.54
Shares outstanding: 51190708
Book value: 1334348000
P/B ratio: 22.271741421518225
Market cap (USD): 29718253622.32
Debt to equity: 0.5904111970790229
Current ratio: 1.986755951117188
Quick ratio: 1.986755951117188
Interest coverage ratio: -27.383846356222048
COGS to revenue (%): 15.591066384668906
R&D to revenue (%): 28.46449454666095
SG&A to revenue (%): 60.74052058998355
Free cash flow (dilution-adjusted): -181554000
Buyback yield (%): 0
Retained earnings: -804437000
Receivables turnover: 7.349163401658635
Capitalized R&D asset: 913899740
ROCI (R&D-adjusted, %): 5.270732111667423
Rosenberg metric: 0.9251100623950844
FCF margin (%): -8.365657096252471
Revenue growth (%): 25.37659542140847
Rule of 40 score: 17.010938325155998
Financial ratios for HUBS — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 531.6
Shares outstanding: 51190708
Market cap (USD): 27212980372.800003
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HUBS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 696.77
Shares outstanding: 51190708
Market cap (USD): 35668149613.159996
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HUBS — annual report dated 2024-12-31
Total revenue: 2627543000
Gross profit: 2234278000
Operating income: -63612000
Net income: 4628000
Capital expenditures: 37939000
Operating cash flow: 598599000
Depreciation & amortization: 96828000
Net tangible assets: 1506731000
Owner earnings: 63517000
Return on net tangible assets (%): 4.215550088237382
Buffett classification: The Gruesome
Stock price: 696.77
P/E ratio: 7707.033192126189
Shares outstanding: 51190708
Book value: 1908286000
P/B ratio: 18.691197028726304
Market cap (USD): 35668149613.159996
Debt to equity: 0.3906206931246155
Current ratio: 1.6738303507247685
Quick ratio: 1.6738303507247685
Effective tax rate (%): 83.8616312724483
Interest coverage ratio: -17.095404461166353
COGS to revenue (%): 14.967024326528625
R&D to revenue (%): 29.636584444098535
SG&A to revenue (%): 57.817360172602314
Free cash flow (dilution-adjusted): -34977000
Buyback yield (%): 0
Retained earnings: -799809000
Receivables turnover: 7.847417637062501
Capitalized R&D asset: 1338470410
ROCI (R&D-adjusted, %): 2.8721635917207897
Rosenberg metric: 0.6514176561526196
FCF margin (%): -1.3311675584376734
Revenue growth (%): 21.072098349022912
Rule of 40 score: 19.74093079058524
Financial ratios for HUBS — quarterly report dated 2025-03-31
Total revenue: 714137000
Gross profit: 599030000
Operating income: -26400000
Net income: -21793000
Capital expenditures: 13345000
Operating cash flow: 161570000
Depreciation & amortization: 28830000
Net tangible assets: 1538933000
Owner earnings: -6308000
Return on net tangible assets (%): -0.40989438786483884
Buffett classification: The Gruesome
Stock price: 571.29
Shares outstanding: 51190708
Book value: 2004544000
P/B ratio: 14.589223071840776
Market cap (USD): 29244739573.32
Debt to equity: 0.3268319378372338
Current ratio: 1.6573941505220349
Quick ratio: 1.6573941505220349
Interest coverage ratio: -40.993788819875775
COGS to revenue (%): 16.11833583752137
R&D to revenue (%): 30.820416810780003
SG&A to revenue (%): 56.75801701914338
Free cash flow (dilution-adjusted): 1111000
Buyback yield (%): 0
Retained earnings: -821602000
Receivables turnover: 2.42483930881569
Capitalized R&D asset: 220100000
ROCI (R&D-adjusted, %): 4.738805196250857
FCF margin (%): 0.15557239017163374
Rule of 40 score: 0.15557239017163374
Financial ratios for HUBS — quarterly report dated 2025-06-30
Total revenue: 760866000
Gross profit: 638705000
Operating income: -23509000
Net income: -3258000
Capital expenditures: 16025000
Operating cash flow: 164362000
Depreciation & amortization: 33194000
Net tangible assets: 1559224000
Owner earnings: 13911000
Buffett classification: The Gruesome
Stock price: 556.63
Shares outstanding: 51190708
Book value: 2065056000
P/B ratio: 13.79831045455426
Market cap (USD): 28494283794.04
Debt to equity: 0.13584716346675343
Current ratio: 1.7947349443280511
Quick ratio: 1.7947349443280511
Interest coverage ratio: -103.56387665198238
COGS to revenue (%): 16.055520945869574
R&D to revenue (%): 31.193403306232636
SG&A to revenue (%): 55.84084451138571
Free cash flow (dilution-adjusted): -28330000
Buyback yield (%): 0.4386985154760985
Retained earnings: -824860000
Receivables turnover: 2.36934689797558
Capitalized R&D asset: 384807000
ROCI (R&D-adjusted, %): 2.2053259821269062
Rosenberg metric: 0.18025897319400272
FCF margin (%): -3.723388875307873
Revenue growth (%): 6.543422340531299
Rule of 40 score: 2.8200334652234256
Financial ratios for HUBS — quarterly report dated 2025-09-30
Total revenue: 809518000
Gross profit: 676000000
Operating income: 12271000
Net income: 16536000
Capital expenditures: 10345000
Operating cash flow: 187355000
Depreciation & amortization: 35702000
Net tangible assets: 1337477000
Owner earnings: 41893000
Return on net tangible assets (%): 3.132240778719933
Capex to operating income (%): 84.30445766441203
Buffett classification: The Gruesome
Stock price: 467.8
P/E ratio: 362.0436200169328
Shares outstanding: 51190708
Book value: 1855842000
P/B ratio: 12.903584034847794
Market cap (USD): 23947013202.4
Debt to equity: 0.1465302541918978
Current ratio: 1.6066567729218386
Quick ratio: 1.6066567729218386
Effective tax rate (%): 28.526970954356845
Interest coverage ratio: 3067.75
COGS to revenue (%): 16.493518365249447
R&D to revenue (%): 28.12957834167986
SG&A to revenue (%): 53.86106300292273
Free cash flow (dilution-adjusted): 4403000
Buyback yield (%): 1.5044423158537923
Retained earnings: -808324000
Receivables turnover: 2.5739022606594384
Capitalized R&D asset: 459364800
ROCI (R&D-adjusted, %): 0.43845329511743153
Rosenberg metric: 0.1571374399595517
FCF margin (%): 0.543903903310365
Revenue growth (%): 6.394292818972066
Rule of 40 score: 6.938196722282431
Financial ratios for HUBS — quarterly report dated 2025-12-31
Total revenue: 846746000
Gross profit: 709045000
Operating income: 49056000
Net income: 54426000
Capital expenditures: 13450000
Operating cash flow: 247430000
Depreciation & amortization: 38569000
Net tangible assets: 1525773000
Owner earnings: 79545000
Return on net tangible assets (%): 5.213422966588084
Capex to operating income (%): 27.41764514024788
Buffett classification: The Good
Stock price: 401.3
P/E ratio: 447.4490017729956
Shares outstanding: 51190708
Book value: 2066244000
P/B ratio: 9.942112896831159
Market cap (USD): 20542831120.4
Debt to equity: 0.12694773705331994
Current ratio: 1.6693583723289933
Quick ratio: 1.6693583723289933
Effective tax rate (%): 11.726352666407163
COGS to revenue (%): 16.262373840561395
R&D to revenue (%): 26.075351994576884
SG&A to revenue (%): 51.868801269802276
Free cash flow (dilution-adjusted): 71317000
Buyback yield (%): 0.07178173209707461
Retained earnings: -753898000
Receivables turnover: 2.0201695829138298
Capitalized R&D asset: 451682580
ROCI (R&D-adjusted, %): 1.452692018884587
Rosenberg metric: 0.14511624230394266
FCF margin (%): 8.422478523665893
Revenue growth (%): 4.598785944228541
Rule of 40 score: 13.021264467894433
Financial ratios for HUBS — annual report dated 2025-12-31
Total revenue: 3131266000
Gross profit: 2622779000
Operating income: 11415000
Net income: 45911000
Capital expenditures: 53165000
Operating cash flow: 760717000
Depreciation & amortization: 136295000
Net tangible assets: 1525773000
Owner earnings: 129041000
Return on net tangible assets (%): 8.457417977641498
Capex to operating income (%): 465.74682435392026
Buffett classification: The Gruesome
Stock price: 401.3
P/E ratio: 447.4490017729956
Shares outstanding: 51190708
Book value: 2066244000
P/B ratio: 9.942112896831159
Market cap (USD): 20542831120.4
Debt to equity: 0.12694773705331994
Current ratio: 1.6693583723289933
Quick ratio: 1.6693583723289933
Effective tax rate (%): 33.90582036479853
Interest coverage ratio: 13.030821917808218
COGS to revenue (%): 16.239022810582046
R&D to revenue (%): 28.93216354024219
SG&A to revenue (%): 54.4642646137377
Free cash flow (dilution-adjusted): 48501000
Buyback yield (%): 2.4340315951069544
Retained earnings: -753898000
Receivables turnover: 7.470585428466453
Capitalized R&D asset: 1631537230
ROCI (R&D-adjusted, %): 3.730277834348608
Rosenberg metric: 0.49890075175224796
FCF margin (%): 1.5489262170636413
Revenue growth (%): 19.170875605080486
Rule of 40 score: 20.719801822144127
Financial ratios for IRD.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.19548872180451127
Shares outstanding: 840192775
Market cap (USD): 164248211.65413532
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IRD.AX — annual report dated 2022-06-30
Operating income: -2669305.5172413792
Net income: -2776520.6896551726
Capital expenditures: 641497.2413793104
Depreciation & amortization: 32293.793103448275
Net tangible assets: 92290997.24137932
Owner earnings: -3385724.137931035
Return on net tangible assets (%): -3.6685313184729806
Buffett classification: The Gruesome
Stock price: 0.09655172413793105
Shares outstanding: 840192775
Book value: 92290997.24137932
P/B ratio: 0.8789813032609763
Market cap (USD): 81122061.03448276
Debt to equity: 0
Current ratio: 1.080280483155696
Quick ratio: 1.080280483155696
Interest coverage ratio: -24.890630225080386
Free cash flow (dilution-adjusted): -2917785.5172413792
Buyback yield (%): 0.022576451491827486
Retained earnings: -36661314.48275862
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.8921638559759724
Rule of 40 score: 0
Financial ratios for IRD.AX — annual report dated 2023-06-30
Operating income: -922225.8278145696
Net income: -310217.880794702
Capital expenditures: 3468.8741721854303
Depreciation & amortization: 30063.576158940396
Net tangible assets: 87644800
Owner earnings: -283623.178807947
Return on net tangible assets (%): -0.32360525531229123
Buffett classification: The Gruesome
Stock price: 0.046357615894039736
Shares outstanding: 840192775
Book value: 87644800
P/B ratio: 0.4443998268054391
Market cap (USD): 38949333.94039735
Debt to equity: 0
Current ratio: 0.5268718082210407
Quick ratio: 0.5268718082210407
Interest coverage ratio: -18.301498225785256
Free cash flow (dilution-adjusted): -817215.8940397351
Buyback yield (%): 0.01944961806107958
Retained earnings: -35514791.39072847
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.0521904239648272
Rule of 40 score: 0
Financial ratios for IRD.AX — annual report dated 2024-06-30
Operating income: -1537330.6666666667
Net income: -992408.6666666666
Capital expenditures: 1999.3333333333333
Depreciation & amortization: 27392.666666666668
Net tangible assets: 88293958.66666667
Owner earnings: -967015.3333333334
Return on net tangible assets (%): -1.0952225361013375
Buffett classification: The Gruesome
Stock price: 0.05333333333333334
Shares outstanding: 840192775
Book value: 88293958.66666666
P/B ratio: 0.5075124279171144
Market cap (USD): 44810281.333333336
Debt to equity: 0
Current ratio: 0.8609635521415874
Quick ratio: 0.8609635521415874
Free cash flow (dilution-adjusted): -1554565.3333333333
Buyback yield (%): 0.056976507563993264
Retained earnings: -36743965.333333336
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.7410198703712576
Rule of 40 score: 0
Financial ratios for JNJ — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 150.49
Shares outstanding: 2409898597
Market cap (USD): 362665639862.53
Buyback yield (%): 0
Retained earnings: 123060000000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for JNJ — annual report dated 2022-12-31
Total revenue: 79990000000
Gross profit: 55394000000
Operating income: 21013000000
Net income: 17941000000
Capital expenditures: 4009000000
Operating cash flow: 21194000000
Depreciation & amortization: 6970000000
Net tangible assets: 2268000000
Owner earnings: 20902000000
Return on net tangible assets (%): 921.6049382716049
Capex to operating income (%): 19.07866558796935
Buffett classification: The Great
Stock price: 159.48
P/E ratio: 21.421917855724875
Shares outstanding: 2409898597
Book value: 76804000000
P/B ratio: 5.004044428018853
Market cap (USD): 384330628249.56
Debt to equity: 0.51614499244831
Current ratio: 0.9908963836421634
Quick ratio: 0.8068886419841583
Effective tax rate (%): 15.439847099540266
Interest coverage ratio: 76.1340579710145
COGS to revenue (%): 30.74884360545068
R&D to revenue (%): 17.670958869858733
SG&A to revenue (%): 25.310663832979124
Free cash flow (dilution-adjusted): 16047000000
Buyback yield (%): 1.5702625698832549
Retained earnings: 128345000000
Inventory turnover: 2.395403194390339
Receivables turnover: 4.728938811705587
Capitalized R&D asset: 14135000000
ROCI (R&D-adjusted, %): 20.88815074588283
FCF margin (%): 20.06125765720715
Rule of 40 score: 20.06125765720715
Financial ratios for JNJ — annual report dated 2023-12-31
Total revenue: 85159000000
Gross profit: 58606000000
Operating income: 22009000000
Net income: 35153000000
Capital expenditures: 4543000000
Operating cash flow: 22791000000
Depreciation & amortization: 7486000000
Net tangible assets: -1959000000
Owner earnings: 38096000000
Return on net tangible assets (%): -1944.6656457376212
Capex to operating income (%): 20.64155572720251
Buffett classification: The Great
Stock price: 145.8
P/E ratio: 9.995255467317158
Shares outstanding: 2409898597
Book value: 68774000000
P/B ratio: 5.108954189702504
Market cap (USD): 351363215442.60004
Debt to equity: 0.4264983860179719
Current ratio: 1.1558489261483946
Quick ratio: 0.9142647249470637
Effective tax rate (%): 11.525693798964282
Interest coverage ratio: 28.509067357512954
COGS to revenue (%): 31.180497657323357
R&D to revenue (%): 17.71392336687843
SG&A to revenue (%): 25.260982397632663
Free cash flow (dilution-adjusted): 16616000000
Buyback yield (%): 1.438397583433329
Retained earnings: 153843000000
Inventory turnover: 2.3748323048027906
Receivables turnover: 4.392582658482488
Capitalized R&D asset: 24555450000
ROCI (R&D-adjusted, %): 18.75727080818301
Rosenberg metric: 0.2272373540856031
FCF margin (%): 19.511736868680938
Revenue growth (%): 6.462057757219652
Rule of 40 score: 25.973794625900588
Financial ratios for JNJ — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 154.28
Shares outstanding: 2409898597
Market cap (USD): 371799155545.16
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for JNJ — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 138.78
Shares outstanding: 2409898597
Market cap (USD): 334445727291.66
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for JNJ — annual report dated 2024-12-31
Total revenue: 88821000000
Gross profit: 61350000000
Operating income: 21249000000
Net income: 14066000000
Capital expenditures: 4424000000
Operating cash flow: 24266000000
Depreciation & amortization: 7339000000
Net tangible assets: -10328000000
Owner earnings: 16981000000
Return on net tangible assets (%): -164.41711851278077
Capex to operating income (%): 20.819803284860463
Buffett classification: The Great
Stock price: 138.78
P/E ratio: 23.77688947047206
Shares outstanding: 2409898597
Book value: 71490000000
P/B ratio: 4.678216915535879
Market cap (USD): 334445727291.66
Debt to equity: 0.512435305637152
Current ratio: 1.1107291190556627
Quick ratio: 0.863436736153892
Effective tax rate (%): 15.706837658057172
Interest coverage ratio: 28.144370860927154
COGS to revenue (%): 30.92849663930827
R&D to revenue (%): 19.4008173742696
SG&A to revenue (%): 25.747289492349783
Free cash flow (dilution-adjusted): 16883000000
Buyback yield (%): 0.7271732904750572
Inventory turnover: 2.207569913211186
Receivables turnover: 4.69281978126486
Capitalized R&D asset: 32003500000
ROCI (R&D-adjusted, %): 14.214412203737641
Rosenberg metric: 0.18190255220417634
FCF margin (%): 19.007892277727116
Revenue growth (%): 4.300191406662831
Rule of 40 score: 23.30808368438995
Financial ratios for JNJ — quarterly report dated 2025-03-31
Total revenue: 21893000000
Gross profit: 14536000000
Operating income: 6199000000
Net income: 10999000000
Capital expenditures: 795000000
Operating cash flow: 4174000000
Depreciation & amortization: 1772000000
Net tangible assets: -3114000000
Owner earnings: 11976000000
Return on net tangible assets (%): -384.58574181117535
Capex to operating income (%): 12.824649136957575
Buffett classification: The Great
Stock price: 160.42
P/E ratio: 8.78707002751932
Shares outstanding: 2409898597
Book value: 78109000000
P/B ratio: 4.94944158715052
Market cap (USD): 386595932930.74
Debt to equity: 0.6689626035412053
Current ratio: 1.2574205226437973
Quick ratio: 1.0349542203398767
Effective tax rate (%): 19.308928178416842
Interest coverage ratio: 30.387254901960784
COGS to revenue (%): 33.60434842187001
R&D to revenue (%): 14.730735851642077
SG&A to revenue (%): 23.34992920111451
Free cash flow (dilution-adjusted): 3077000000
Buyback yield (%): 0.5501868537197103
Inventory turnover: 0.5811675487795245
Receivables turnover: 1.3666042446941324
Capitalized R&D asset: 3225000000
ROCI (R&D-adjusted, %): 5.963869622052531
FCF margin (%): 14.054720686977573
Rule of 40 score: 14.054720686977573
Financial ratios for JNJ — quarterly report dated 2025-06-30
Total revenue: 23743000000
Gross profit: 16115000000
Operating income: 6710000000
Net income: 5537000000
Capital expenditures: 1043000000
Operating cash flow: 3878000000
Depreciation & amortization: 1943000000
Net tangible assets: -19479000000
Owner earnings: 6437000000
Return on net tangible assets (%): -33.04584424251759
Capex to operating income (%): 15.543964232488822
Buffett classification: The Great
Stock price: 149.03
P/E ratio: 21.71910908991957
Shares outstanding: 2409898597
Book value: 78473000000
P/B ratio: 4.576697563632204
Market cap (USD): 359147187910.91
Debt to equity: 0.6468594293578683
Current ratio: 1.0058693244739756
Quick ratio: 0.7583241048357328
Effective tax rate (%): 14.697273147434911
Interest coverage ratio: 21.785714285714285
COGS to revenue (%): 32.12736385460978
R&D to revenue (%): 14.80857515899423
SG&A to revenue (%): 24.803099861011667
Free cash flow (dilution-adjusted): 2070000000
Buyback yield (%): 0
Inventory turnover: 0.5687444079928422
Receivables turnover: 1.330438193432702
Capitalized R&D asset: 5676750000
ROCI (R&D-adjusted, %): 5.507097833982983
Rosenberg metric: 0.4896124031007752
FCF margin (%): 8.718359095312303
Revenue growth (%): 8.450189558306308
Rule of 40 score: 17.16854865361861
Financial ratios for JNJ — quarterly report dated 2025-09-30
Total revenue: 23993000000
Gross profit: 16690000000
Operating income: 7096000000
Net income: 5152000000
Capital expenditures: 1157000000
Operating cash flow: 9169000000
Depreciation & amortization: 1777000000
Net tangible assets: -17508000000
Owner earnings: 5772000000
Return on net tangible assets (%): -32.96778615490062
Capex to operating income (%): 16.304960541149942
Buffett classification: The Great
Stock price: 182.23
P/E ratio: 20.248792942240406
Shares outstanding: 2409898597
Book value: 79277000000
P/B ratio: 5.539511098191279
Market cap (USD): 439155821331.31
Debt to equity: 0.5776580849426693
Current ratio: 1.073561501110696
Quick ratio: 0.7954746505730406
Effective tax rate (%): 31.242492993460562
Interest coverage ratio: 28.963265306122448
COGS to revenue (%): 30.438044429625304
R&D to revenue (%): 15.304463801942234
SG&A to revenue (%): 24.682198974700956
Free cash flow (dilution-adjusted): 7649000000
Buyback yield (%): 0.43310367473532463
Inventory turnover: 0.5162590131485932
Receivables turnover: 1.3623871443983873
Capitalized R&D asset: 7091970000
ROCI (R&D-adjusted, %): 4.896034909527354
Rosenberg metric: 0.16353811149032993
FCF margin (%): 31.88013170508065
Revenue growth (%): 1.052941919723708
Rule of 40 score: 32.93307362480436
Financial ratios for JNJ — quarterly report dated 2025-12-31
Total revenue: 24564000000
Gross profit: 16596000000
Operating income: 5591000000
Net income: 5116000000
Capital expenditures: 1837000000
Operating cash flow: 7309000000
Depreciation & amortization: 2011000000
Net tangible assets: -17631000000
Owner earnings: 5290000000
Return on net tangible assets (%): -30.00397027962112
Capex to operating income (%): 32.85637631908424
Buffett classification: The Good
Stock price: 204.68
P/E ratio: 18.402404299132964
Shares outstanding: 2409898597
Book value: 81544000000
P/B ratio: 6.04898024175856
Market cap (USD): 493258044833.96
Debt to equity: 0.5878176199352497
Current ratio: 1.027676163027011
Quick ratio: 0.7654916306396187
Effective tax rate (%): -3.020539669754329
Interest coverage ratio: 26.126168224299064
COGS to revenue (%): 32.437713727405956
R&D to revenue (%): 17.30988438365087
SG&A to revenue (%): 27.491450903761606
Free cash flow (dilution-adjusted): 5163000000
Buyback yield (%): 0.3900595276956212
Inventory turnover: 0.5614826298358114
Receivables turnover: 1.1515634522525902
Capitalized R&D asset: 7872520000
ROCI (R&D-adjusted, %): 3.9420788774918956
Rosenberg metric: -0.02559912854030501
FCF margin (%): 21.018563751831948
Revenue growth (%): 2.3798607927312134
Rule of 40 score: 23.398424544563163